Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: J Allergy Clin Immunol. 2018 Aug 28;143(4):1474–1481.e8. doi: 10.1016/j.jaci.2018.07.036

Table II.

in vitro IgE potencies of cockroach extracts for five cockroach allergic subjects.

Cockroach allergic subjects
1445 1277 1424 1425 1864
Cockroach extracts Relative extract potencies (Normalized IC30 data)*
#1 Commercial - WB - Hum 3.7 4.3 1.7 2.0 1.9
#2 Commercial - WB - Hum 0.8 1.2 1.9 1.3 1.1
#3 Commercial - WB - Hum 0.4 0.6 1.3 1.6 1.3
#4 Commercial - WB - Hum 0.7 0.9 1.9 1.7 1.1
#5 Commercial - WB - Vet 944.4 1000.0 350.0 25.0 1.8
#6 Commercial - WB - Vet 0.8 0.4 1.6 2.8 1.5
#7 Commercial - WB - Res 9.4 12.5 2.7 2.9 2.1
#8 Commercial - WB - Res 15.0 187.5 1.0 1.0 1.0
#9 Commercial - WB - Res 1.0 1.0 1.0 1.0 1.0
#10 In-house - Fecal - Res 444.4 1000.0 45.8 153.9 4.3
#11 In-house - Fecal - Res 1055.6 1000.0 3.0 10.0 15.5
#12 In-house - Frass - Res 1000.0 1000.0 22.5 12.2 1.6
#13 Negative control 1000.0 1000.0 1000.0 1000.0 1000.0
x2375 x2720 x1000 x1000 xl000
*

Absolute in vitro potencies expressed in μg/mL were transformed into in vitro potencies (without units) relative to the values for extract #9 used as reference (potency of 1, underlined). 1000 was added for curves that did not reach the IC30.

Abbreviations: WB: whole body; Hum: human use; Vet: veterinary use; Res: research use.